352 related articles for article (PubMed ID: 29200843)
1. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
[TBL] [Abstract][Full Text] [Related]
2. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
3. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?
Saltürk C; Karakurt Z; Adiguzel N; Kargin F; Sari R; Celik ME; Takir HB; Tuncay E; Sogukpinar O; Ciftaslan N; Mocin O; Gungor G; Oztas S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1837-46. PubMed ID: 26392758
[TBL] [Abstract][Full Text] [Related]
4. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
5. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation?
Çoban Ağca M; Aksoy E; Duman D; Özmen İ; Yıldırım E; Güngör S; Durmuş N; Aka Aktürk Ü; Saltürk C; Tepetam FM; Karakurt Z
Tuberk Toraks; 2017 Dec; 65(4):282-290. PubMed ID: 29631526
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.
Cai C; Zeng W; Wang H; Ren S
Int J Chron Obstruct Pulmon Dis; 2024; 19():933-943. PubMed ID: 38646605
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes.
Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N
Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162
[TBL] [Abstract][Full Text] [Related]
9. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
[TBL] [Abstract][Full Text] [Related]
10. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.
Pascual-González Y; López-Sánchez M; Dorca J; Santos S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3651-3662. PubMed ID: 30464448
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.
Kang HS; Rhee CK; Kim SK; Kim JW; Lee SH; Yoon HK; Ahn JH; Kim YH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2467-2473. PubMed ID: 27757029
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study.
Günay E; Sarınç Ulaşlı S; Akar O; Ahsen A; Günay S; Koyuncu T; Unlü M
Inflammation; 2014 Apr; 37(2):374-80. PubMed ID: 24078279
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation.
Tang B; Huang D; Wang J; Luo LL; Li QG
Med Sci Monit; 2020 Mar; 26():e921182. PubMed ID: 32161254
[TBL] [Abstract][Full Text] [Related]
16. A new predictor to determine the exacerbation and treatment of chronic obstructive pulmonary disease: eosinophil/neutrophil ratio.
Yakar Hİ; Kanbay A
Tuberk Toraks; 2020 Sep; 68(3):260-267. PubMed ID: 33295724
[TBL] [Abstract][Full Text] [Related]
17. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.
Sakurai K; Chubachi S; Irie H; Tsutsumi A; Kameyama N; Kamatani T; Koh H; Terashima T; Nakamura H; Asano K; Betsuyaku T
BMC Pulm Med; 2018 May; 18(1):65. PubMed ID: 29720140
[TBL] [Abstract][Full Text] [Related]
19. The Neutrophil/Lymphocyte Ratio Could Predict Noninvasive Mechanical Ventilation Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study.
Sun W; Luo Z; Jin J; Cao Z; Ma Y
Int J Chron Obstruct Pulmon Dis; 2021; 16():2267-2277. PubMed ID: 34385816
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients.
El-Gazzar AG; Kamel MH; Elbahnasy OKM; El-Naggar ME
Expert Rev Respir Med; 2020 Jan; 14(1):111-116. PubMed ID: 31577911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
